Literature DB >> 3873705

Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III.

P J Kanki, M F McLane, N W King, N L Letvin, R D Hunt, P Sehgal, M D Daniel, R C Desrosiers, M Essex.   

Abstract

Human T-lymphotropic virus type III (HTLV-III) is thought to play an etiologic role in the development of the acquired immune deficiency syndrome (AIDS). In this study the serologic characterization of a new simian retrovirus that is related to HTLV-III is described. This new virus, here referred to as STLV-III, was isolated from sick macaques at the New England Regional Primate Research Center. Radioimmunoprecipitation analysis revealed STLV-III-specific proteins of 160, 120, 55, and 24 kilodaltons, all similar in size to the major gag and env proteins of HTLV-III. These antigens were recognized by representative macaque serum samples and human reference serum samples positive for HTLV-III antibodies. Monoclonal antibodies directed to p24, the major core protein of HTLV-III, also immunoprecipitated a 24-kilodalton species in lysates of cells infected with the macaque virus. This HTLV-III-related virus, which naturally infects a nonhuman primate species, may provide a useful model for the study of HTLV-III and the pathogenesis of AIDS.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3873705     DOI: 10.1126/science.3873705

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  69 in total

1.  Effects of soluble CD4 on simian immunodeficiency virus infection of CD4-positive and CD4-negative cells.

Authors:  D Schenten; L Marcon; G B Karlsson; C Parolin; T Kodama; N Gerard; J Sodroski
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages.

Authors:  N Hattori; F Michaels; K Fargnoli; L Marcon; R C Gallo; G Franchini
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

3.  Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants.

Authors:  P Kolchinsky; E Kiprilov; J Sodroski
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Self-reported health care over the past 10 years: a survey of general practitioners.

Authors:  R Chambers; J Belcher
Journal:  Br J Gen Pract       Date:  1992-04       Impact factor: 5.386

5.  Analysis of the transcription pattern and mapping of the putative rev and env splice junctions of bovine immunodeficiency-like virus.

Authors:  M S Oberste; J D Greenwood; M A Gonda
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

6.  Isolation from African Sykes' monkeys (Cercopithecus mitis) of a lentivirus related to human and simian immunodeficiency viruses.

Authors:  P Emau; H M McClure; M Isahakia; J G Else; P N Fultz
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

7.  Comparison of the transcriptional activity of the long terminal repeats of simian immunodeficiency viruses SIVmac251 and SIVmac239 in T-cell lines and macrophage cell lines.

Authors:  M G Anderson; J E Clements
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

8.  Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1.

Authors:  J F Zagury; G Franchini; M Reitz; E Collalti; B Starcich; L Hall; K Fargnoli; L Jagodzinski; H G Guo; F Laure
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

Review 9.  Origin and diversity of human retroviruses.

Authors:  Martine Peeters; Mirela D'Arc; Eric Delaporte
Journal:  AIDS Rev       Date:  2014 Jan-Mar       Impact factor: 2.500

10.  Isolation of a simian immunodeficiency virus related to human immunodeficiency virus type 2 from a west African pet sooty mangabey.

Authors:  P A Marx; Y Li; N W Lerche; S Sutjipto; A Gettie; J A Yee; B H Brotman; A M Prince; A Hanson; R G Webster
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.